Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01664130 · ClinicalTrials.gov registry record · NA
High-Dose Stereotactic Radiation for Prostate Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01664130 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 35 participants.
The verdict
NCT01664130, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This clinical trial studies high-dose stereotactic body radiation therapy (SBRT) in treating patients with low-, intermediate-, or high-risk localized prostate cancer. SBRT may be able to send x-rays directly to the tumor and cause less damage to normal tissue
Interventions
- OTHER laboratory biomarker analysis
- RADIATION stereotactic body radiation therapy
- PROCEDURE quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-07 |
| Est. Completion | 2017-01-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01664130
The ClinicalTrials.gov registry entry for NCT01664130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01664130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01664130 about?
NCT01664130 is a clinical study titled "High-Dose Stereotactic Radiation for Prostate Cancer". This clinical trial studies high-dose stereotactic body radiation therapy (SBRT) in treating patients with low-, intermediate-, or high-risk localized prostate cancer. SBRT may be able to send x-rays directly to the tumor and cause less damage to normal tissue
What is the current status of trial NCT01664130?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-07. Estimated completion is 2017-01-12.
What interventions are being tested in trial NCT01664130?
The interventions under investigation include: laboratory biomarker analysis (OTHER), stereotactic body radiation therapy (RADIATION), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT01664130?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.